Screening for symptomatic metal sensitivity: A prospective study of 92 patients undergoing total knee arthroplasty

Yasuo Niki, Hideo Matsumoto, Toshiro Otani, Taku Yatabe, Makoto Kondo, Fumihiro Yoshimine, Yoshiaki Toyama

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Metal sensitivity (MS) reactions to implant metals represent a rare but well-documented complication following total joint arthroplasty (TJA). Although 20-25% of post-TJA patients develop MS, only a few highly susceptible patients (<1%) exhibit symptoms. Whether surgeons should perform screening for MS is currently a matter of debate. The present study investigated the clinical importance of screening for patients predisposed to symptomatic MS, and the specific metals causing symptomatic MS following total knee arthroplasty (TKA). Between 2000 and 2002, a total of 108 primary TKAs were performed on 92 patients. Preoperatively, all patients underwent modified lymphocyte stimulation test (mLST) to Ni, Co, Cr, and Fe. Of the 92 patients, 24 (26%) displayed positive preoperative responses to at least one metal. Five patients displayed implant metal-related eczema and were all mLST-positive preoperatively, suggesting that screening for symptomatic MS is clinically useful. Two of these underwent revision TKA and thereafter, eczema healed and mLST results changed from positive to negative. All mLST-positive patients were divided into three groups: Group I, patients with eczema; Group II, patients with clear history of MS; and Group III, patients neither eczema nor history of MS. When the type of sensitive metals were compared among the three groups, a significant association between presence of Cr-sensitivity and development of eczema (P<0.05) was identified. No significant association was observed between other metals and development of eczema or history of MS. This indicates that Cr is a potential candidate metal for causing eczema in our TKA series, and Cr-sensitivity may offer a potential predictor for symptomatic MS. The present study indicates that the surgeons should undertake routine preoperative screening for MS, particularly to Cr.

Original languageEnglish
Pages (from-to)1019-1026
Number of pages8
JournalBiomaterials
Volume26
Issue number9
DOIs
Publication statusPublished - 2005 Mar

Fingerprint

Arthroplasty
Knee Replacement Arthroplasties
Screening
Metals
Prospective Studies
Eczema
Lymphocytes
Lymphocyte Activation
Joints

Keywords

  • Lymphocyte stimulation test
  • Metal sensitivity
  • Screening
  • Total knee arthroplasty

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering

Cite this

Screening for symptomatic metal sensitivity : A prospective study of 92 patients undergoing total knee arthroplasty. / Niki, Yasuo; Matsumoto, Hideo; Otani, Toshiro; Yatabe, Taku; Kondo, Makoto; Yoshimine, Fumihiro; Toyama, Yoshiaki.

In: Biomaterials, Vol. 26, No. 9, 03.2005, p. 1019-1026.

Research output: Contribution to journalArticle

Niki, Yasuo ; Matsumoto, Hideo ; Otani, Toshiro ; Yatabe, Taku ; Kondo, Makoto ; Yoshimine, Fumihiro ; Toyama, Yoshiaki. / Screening for symptomatic metal sensitivity : A prospective study of 92 patients undergoing total knee arthroplasty. In: Biomaterials. 2005 ; Vol. 26, No. 9. pp. 1019-1026.
@article{e83050ca14644979b1b3cf687d9ab1da,
title = "Screening for symptomatic metal sensitivity: A prospective study of 92 patients undergoing total knee arthroplasty",
abstract = "Metal sensitivity (MS) reactions to implant metals represent a rare but well-documented complication following total joint arthroplasty (TJA). Although 20-25{\%} of post-TJA patients develop MS, only a few highly susceptible patients (<1{\%}) exhibit symptoms. Whether surgeons should perform screening for MS is currently a matter of debate. The present study investigated the clinical importance of screening for patients predisposed to symptomatic MS, and the specific metals causing symptomatic MS following total knee arthroplasty (TKA). Between 2000 and 2002, a total of 108 primary TKAs were performed on 92 patients. Preoperatively, all patients underwent modified lymphocyte stimulation test (mLST) to Ni, Co, Cr, and Fe. Of the 92 patients, 24 (26{\%}) displayed positive preoperative responses to at least one metal. Five patients displayed implant metal-related eczema and were all mLST-positive preoperatively, suggesting that screening for symptomatic MS is clinically useful. Two of these underwent revision TKA and thereafter, eczema healed and mLST results changed from positive to negative. All mLST-positive patients were divided into three groups: Group I, patients with eczema; Group II, patients with clear history of MS; and Group III, patients neither eczema nor history of MS. When the type of sensitive metals were compared among the three groups, a significant association between presence of Cr-sensitivity and development of eczema (P<0.05) was identified. No significant association was observed between other metals and development of eczema or history of MS. This indicates that Cr is a potential candidate metal for causing eczema in our TKA series, and Cr-sensitivity may offer a potential predictor for symptomatic MS. The present study indicates that the surgeons should undertake routine preoperative screening for MS, particularly to Cr.",
keywords = "Lymphocyte stimulation test, Metal sensitivity, Screening, Total knee arthroplasty",
author = "Yasuo Niki and Hideo Matsumoto and Toshiro Otani and Taku Yatabe and Makoto Kondo and Fumihiro Yoshimine and Yoshiaki Toyama",
year = "2005",
month = "3",
doi = "10.1016/j.biomaterials.2004.03.038",
language = "English",
volume = "26",
pages = "1019--1026",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "9",

}

TY - JOUR

T1 - Screening for symptomatic metal sensitivity

T2 - A prospective study of 92 patients undergoing total knee arthroplasty

AU - Niki, Yasuo

AU - Matsumoto, Hideo

AU - Otani, Toshiro

AU - Yatabe, Taku

AU - Kondo, Makoto

AU - Yoshimine, Fumihiro

AU - Toyama, Yoshiaki

PY - 2005/3

Y1 - 2005/3

N2 - Metal sensitivity (MS) reactions to implant metals represent a rare but well-documented complication following total joint arthroplasty (TJA). Although 20-25% of post-TJA patients develop MS, only a few highly susceptible patients (<1%) exhibit symptoms. Whether surgeons should perform screening for MS is currently a matter of debate. The present study investigated the clinical importance of screening for patients predisposed to symptomatic MS, and the specific metals causing symptomatic MS following total knee arthroplasty (TKA). Between 2000 and 2002, a total of 108 primary TKAs were performed on 92 patients. Preoperatively, all patients underwent modified lymphocyte stimulation test (mLST) to Ni, Co, Cr, and Fe. Of the 92 patients, 24 (26%) displayed positive preoperative responses to at least one metal. Five patients displayed implant metal-related eczema and were all mLST-positive preoperatively, suggesting that screening for symptomatic MS is clinically useful. Two of these underwent revision TKA and thereafter, eczema healed and mLST results changed from positive to negative. All mLST-positive patients were divided into three groups: Group I, patients with eczema; Group II, patients with clear history of MS; and Group III, patients neither eczema nor history of MS. When the type of sensitive metals were compared among the three groups, a significant association between presence of Cr-sensitivity and development of eczema (P<0.05) was identified. No significant association was observed between other metals and development of eczema or history of MS. This indicates that Cr is a potential candidate metal for causing eczema in our TKA series, and Cr-sensitivity may offer a potential predictor for symptomatic MS. The present study indicates that the surgeons should undertake routine preoperative screening for MS, particularly to Cr.

AB - Metal sensitivity (MS) reactions to implant metals represent a rare but well-documented complication following total joint arthroplasty (TJA). Although 20-25% of post-TJA patients develop MS, only a few highly susceptible patients (<1%) exhibit symptoms. Whether surgeons should perform screening for MS is currently a matter of debate. The present study investigated the clinical importance of screening for patients predisposed to symptomatic MS, and the specific metals causing symptomatic MS following total knee arthroplasty (TKA). Between 2000 and 2002, a total of 108 primary TKAs were performed on 92 patients. Preoperatively, all patients underwent modified lymphocyte stimulation test (mLST) to Ni, Co, Cr, and Fe. Of the 92 patients, 24 (26%) displayed positive preoperative responses to at least one metal. Five patients displayed implant metal-related eczema and were all mLST-positive preoperatively, suggesting that screening for symptomatic MS is clinically useful. Two of these underwent revision TKA and thereafter, eczema healed and mLST results changed from positive to negative. All mLST-positive patients were divided into three groups: Group I, patients with eczema; Group II, patients with clear history of MS; and Group III, patients neither eczema nor history of MS. When the type of sensitive metals were compared among the three groups, a significant association between presence of Cr-sensitivity and development of eczema (P<0.05) was identified. No significant association was observed between other metals and development of eczema or history of MS. This indicates that Cr is a potential candidate metal for causing eczema in our TKA series, and Cr-sensitivity may offer a potential predictor for symptomatic MS. The present study indicates that the surgeons should undertake routine preoperative screening for MS, particularly to Cr.

KW - Lymphocyte stimulation test

KW - Metal sensitivity

KW - Screening

KW - Total knee arthroplasty

UR - http://www.scopus.com/inward/record.url?scp=4444313276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444313276&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2004.03.038

DO - 10.1016/j.biomaterials.2004.03.038

M3 - Article

C2 - 15369690

AN - SCOPUS:4444313276

VL - 26

SP - 1019

EP - 1026

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 9

ER -